Arena Pharmaceuticals Inc - Company & Market Research Reports

Arena Pharmaceuticals is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has one product on the market and several others in development. Lorcaserin is used long term for weight loss in those who are obese. It works by increasing feelings of fullness so that less food is eaten. The U.S. Food and Drug Administration (FDA) approved Lorcaserin on June 27, 2012. Arena Pharmaceuticals is headquartered in Zofingen, Switzerland.

Pain Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Pain Drug Development Pipeline Review, 2018

  • Report
  • 148 Pages
From
Cardiovascular Disorders Drug Development Pipeline Review, 2017 - Product Thumbnail Image

Cardiovascular Disorders Drug Development Pipeline Review, 2017

  • Report
  • 432 Pages
From
Anti-Obesity Drugs - Global Strategic Business Report - Product Thumbnail Image

Anti-Obesity Drugs - Global Strategic Business Report

  • Report
  • 143 Pages
From
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018

  • Report
  • 344 Pages
From
Obesity Drugs and Therapies: Technologies and Global Markets - Product Thumbnail Image

Obesity Drugs and Therapies: Technologies and Global Markets

  • Report
From
Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017-2030 - Product Thumbnail Image

Microbiome Therapeutics and Diagnostics Market (2nd Edition), 2017-2030

  • Report
  • 443 Pages
From
Anti-Obesity Prescription Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024 - Product Thumbnail Image

Anti-Obesity Prescription Drugs Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2024

  • Report
  • 100 Pages
From
2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report - Product Thumbnail Image

2018 Gastritis (stomach inflammation) Drug Development- Pipeline Analysis Report

  • Report
  • 40 Pages
From
Global Diabetes and Obesity Drugs Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Diabetes and Obesity Drugs Market Analysis 2016 - Forecast to 2022

  • Report
  • 141 Pages
From
Osteoarthritis Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H2 2017

  • Drug Pipelines
  • 224 Pages
From
Osteoarthritis Pain - Pipeline Review, H1 2017 - Product Thumbnail Image

Osteoarthritis Pain - Pipeline Review, H1 2017

  • Drug Pipelines
  • 202 Pages
From
Neuropathic Pain - Pipeline Review, H2 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H2 2017

  • Drug Pipelines
  • 488 Pages
From
Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018 - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH): Drug Development Pipeline Study, H1 2018

  • Report
  • 118 Pages
From
Neuropathic Pain - Pipeline Review, H1 2017 - Product Thumbnail Image

Neuropathic Pain - Pipeline Review, H1 2017

  • Drug Pipelines
  • 485 Pages
From
Global Anti-Obesity Drugs Market - Growth, Trends & Forecast 2017 - 2022 - Product Thumbnail Image

Global Anti-Obesity Drugs Market - Growth, Trends & Forecast 2017 - 2022

  • Report
  • 205 Pages
From
Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2018 - Product Thumbnail Image

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2018

  • Drug Pipelines
  • 413 Pages
From
Ulcerative Colitis - Pipeline Review, H1 2018 - Product Thumbnail Image

Ulcerative Colitis - Pipeline Review, H1 2018

  • Drug Pipelines
  • 482 Pages
From
Blood Pressure Disorders Drug Development Pipeline Review, 2018 - Product Thumbnail Image

Blood Pressure Disorders Drug Development Pipeline Review, 2018

  • Report
  • 213 Pages
From
Lysosomal Disease Treatments: Technologies and Global Markets - Product Thumbnail Image

Lysosomal Disease Treatments: Technologies and Global Markets

  • Report
  • 118 Pages
From
Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Strategic Business Report

  • Report
  • 161 Pages
From
Loading Indicator
adroll